SILVER POINT CAPITAL L.P. purchased 13.8% of their position (685K shares) of KEENOVA THERAPEUTICS PLC on the open market
Open‑market purchase worth $61.44M — a moderate purchase. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 4/17/2026ACC: 0001193125-26-161818
10% Owner
Since Nov 2025
+685K
Net shares
Net buyer
$61.44M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
685K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+275K
Price / share
$88.50
Trade value
$24.34M
% of position
5.6%
4/15/2026
4.95M→5.23M
Common Stock
Direct
Shares
+410K
Price / share
$90.50
Trade value
$37.10M
% of position
7.8%
4/17/2026
5.23M→5.64M
Total
Net shares
+685K
Net value
$61.44M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/15/2026 | P · Purchase | +275K | $88.50 | $24.34M | 5.6% | 4.95M | 5.23M |
| Common Stock Direct | 4/17/2026 | P · Purchase | +410K | $90.50 | $37.10M | 7.8% | 5.23M | 5.64M |
| Total | +685K | $61.44M | ||||||
Derivative Transactions0
No derivative transactions reported